Last reviewed · How we verify
Anti-pseudomonas IgY gargle
At a glance
| Generic name | Anti-pseudomonas IgY gargle |
|---|---|
| Also known as | oral immunotherapy, Yolk antiboidies |
| Sponsor | Immunsystem AB |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anti-pseudomonas IgY gargle CI brief — competitive landscape report
- Anti-pseudomonas IgY gargle updates RSS · CI watch RSS
- Immunsystem AB portfolio CI